Infection in people with multiple sclerosis (MS) is of major concern, particularly for those receiving disease-modifying therapies. This article explores the risk of infection in people with MS and provides guidance—developed by Delphi consensus by specialists involved in their management—on how to screen for, prevent and manage infection in this population
The increasing number of potent treatments for multiple sclerosis warrants screening for infections....
Some reports suggest that bacteria, including Chlamydophila pneumoniae, could be involved in the eti...
Background: The disease-modifying therapies (DMTs) largely used in multiple sclerosis (MS) may resul...
Infection in people with multiple sclerosis (MS) is of major concern, particularly for those receivi...
Infection in people with multiple sclerosis (MS) is of major concern, particularly for those receivi...
Background: People with multiple sclerosis (pwMS) have an increased risk of infections; risk factors...
The risk of infection associated with immunomodulatory or immunosuppressive disease-modifying drugs ...
: Over the recent years, the treatment of multiple sclerosis (MS) and neuromyelitis optica spectrum ...
Background and purpose: Multiple sclerosis (MS) patients are at increased infection risk. Here the i...
International audienceIntroduction: Viral, bacterial, or fungal infections are suspected of triggeri...
Multiple sclerosis (MS) is the commonest non-traumatic disabling disease to affect young adults. The...
The increasing number of potent treatments for multiple sclerosis warrants screening for infections....
Some reports suggest that bacteria, including Chlamydophila pneumoniae, could be involved in the eti...
Background: The disease-modifying therapies (DMTs) largely used in multiple sclerosis (MS) may resul...
Infection in people with multiple sclerosis (MS) is of major concern, particularly for those receivi...
Infection in people with multiple sclerosis (MS) is of major concern, particularly for those receivi...
Background: People with multiple sclerosis (pwMS) have an increased risk of infections; risk factors...
The risk of infection associated with immunomodulatory or immunosuppressive disease-modifying drugs ...
: Over the recent years, the treatment of multiple sclerosis (MS) and neuromyelitis optica spectrum ...
Background and purpose: Multiple sclerosis (MS) patients are at increased infection risk. Here the i...
International audienceIntroduction: Viral, bacterial, or fungal infections are suspected of triggeri...
Multiple sclerosis (MS) is the commonest non-traumatic disabling disease to affect young adults. The...
The increasing number of potent treatments for multiple sclerosis warrants screening for infections....
Some reports suggest that bacteria, including Chlamydophila pneumoniae, could be involved in the eti...
Background: The disease-modifying therapies (DMTs) largely used in multiple sclerosis (MS) may resul...